Ellen Vercauteren

Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model

Ellen Vercauteren, Jan Emmerechts, Miet Peeters et al. · Blood · 2011 · 48 citations · Full text

Medicine, Immunology, Pharmacology +9

Identification and characterisation of monoclonal antibodies that impair the activation of human thrombin activatable fibrinolysis inhibitor through different mechanisms

Niraj Mishra, Ellen Vercauteren, Jan Develter et al. · Thrombosis and Haemostasis · 2011 · 26 citations

Medicine, Molecular Biology, Pharmacology +14

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

Ellen Vercauteren, Marc Peeters, Marc Hoylaerts et al. · Journal of Thrombosis and Haemostasis · 2012 · 25 citations

Medicine, Genetics, Molecular Biology +12

Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue

Louise Johnston, Michael Power, Philip Sloan et al. · Journal of Clinical Pathology · 2017 · 21 citations · Full text

Medicine, Molecular Genetics, Oncology +17